Cargando…
An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment
Fluvoxamine (FLV) is a well-tolerated, widely accessible antidepressant of the selective serotonin reuptake inhibitor (SSRI) category. It was formerly used to reduce anxiety, obsessive-compulsive disorder, panic attacks, and depression. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is...
Autores principales: | Arishi, Naif A, Althomali, Naif M, Dighriri, Ibrahim M, Alharthi, Mohammed S, Alqurashi, Ghadeer B, Musharraf, Razan A, Albuhayri, Aeshah H, Almalki, Marwah k, Alnami, Shatha A, Mashraqi, Zamzam O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949685/ https://www.ncbi.nlm.nih.gov/pubmed/36843775 http://dx.doi.org/10.7759/cureus.34158 |
Ejemplares similares
-
Determinants of COVID-19 Vaccine Acceptance Among the General Adult Population in Saudi Arabia Based on the Health Belief Model: A Web-Based Cross-Sectional Study
por: Okmi, Ezzuddin A, et al.
Publicado: (2022) -
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis
por: Wen, Wen, et al.
Publicado: (2022) -
The Attributable Factors That Increase the Likelihood of Central Line Associated Blood Stream Infection Related In-Hospital 30-Day Mortality
por: Alotaibi, Naif H, et al.
Publicado: (2023) -
Transmission and Cleaning Misconception During the COVID-19 Pandemic Time in Riyadh, Saudi Arabia
por: Alali, Naif S, et al.
Publicado: (2022) -
COVID-19 Rebound After Paxlovid Treatment: A Case Series and Review of Literature
por: Alshanqeeti, Shatha, et al.
Publicado: (2022)